H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 7.8% of adults in Washington have diagnosed diabetes — 4.2 points below the U.S. 12% figure. Census population 689,545. District of Columbia Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Washington clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Washington storefront.
Skin Substitute Therapy Products in Washington, DC for clinics & physicians. Skin substitute therapy for c… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 7.8% of adults in Washington have diagnosed diabetes — 4.2 points below the U.S. 12% figure. Obesity 24.6%; arthritis 16.9%. Those three PLACES crude rates (plus Census 689,545) are the local facts on this page. Everything else is the national skin substitute therapy catalog and JL paperwork.
National Skin Substitute Therapy Products notes (how the product actually works)District of Columbia shares JL with DE, MD, NJ, PA. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 7.8% of adults in Washington have diagnosed diabetes — 4.2 points below the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 7.8% of adults in Washington have diagnosed diabetes — 4.2 points below the U.S. 12% figure. Adult arthritis here is 16.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Washington.
CDC PLACES (2023, crude prevalence) estimates 7.8% of adults — 4.2 points below the U.S. 12% figure. Obesity is 24.6%; arthritis is 16.9%. That is place-level BRFSS modeling, not a clinic census and not a Washington trial.
No. Organization schema on this site does not publish a fake aggregateRating. Testimonials on marketing pages are not assigned to Washington as local reviews.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
District of Columbia is in CMS MAC JL, administered by Novitas Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
Bring specialty, monthly wound volume, and whether you bill JL FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 7.8% diabetes and 16.9% arthritis for Washington — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Washington, DC.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Washington is JL geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Washington — 4.2 points below the U.S. 12% figure. Planning input, not an outcomes claim.
District of Columbia Part B wound biologics follow this contractor (siblings: DE, MD, NJ, PA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Washington. Useful for joint-program math; still needs a diagnosis and privileging.
No Washington storefront. Joe Bradley is an active practice owner. skin substitute therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.